These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22118041)

  • 1. Acute coronary syndromes: a Canadian perspective.
    Fitchett DH
    Can J Cardiol; 2011; 27 Suppl A():S385-6. PubMed ID: 22118041
    [No Abstract]   [Full Text] [Related]  

  • 2. Having it both ways.
    Bittl JA; Maron DJ
    J Am Coll Cardiol; 2010 Mar; 55(9):865-6. PubMed ID: 20045277
    [No Abstract]   [Full Text] [Related]  

  • 3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 4. Tug of war.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353
    [No Abstract]   [Full Text] [Related]  

  • 5. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of acute coronary syndromes from a gender perspective.
    Alfredsson J; Swahn E
    Fundam Clin Pharmacol; 2010 Dec; 24(6):719-28. PubMed ID: 20584204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated ESC Guidelines for managing patients with suspected non-ST-elevation acute coronary syndromes.
    Eur Heart J; 2011 Dec; 32(23):2909-10. PubMed ID: 22135069
    [No Abstract]   [Full Text] [Related]  

  • 8. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 10. Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance.
    Hill RA; Chung H; George E; Longson C; Stevens A
    Heart; 2010 Sep; 96(17):1407-8. PubMed ID: 20801857
    [No Abstract]   [Full Text] [Related]  

  • 11. Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes.
    Chew DP; Anderson FA; Avezum A; Eagle KA; FitzGerald G; Gore JM; Dedrick R; Brieger D;
    Heart; 2010 Aug; 96(15):1201-6. PubMed ID: 20530127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 13. The year in cardiology 2015: acute coronary syndromes.
    Montalescot G; Crea F
    Eur Heart J; 2016 Jan; 37(3):221-8. PubMed ID: 26726042
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial treatment of acute coronary syndromes. Is there a future for MONA acronym after the 2010 guidelines?
    Nikolaou NI; Vrints CJ
    Resuscitation; 2012 Jan; 83(1):e7. PubMed ID: 21982924
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
    Caixeta A; Dangas GD; Mehran R; Feit F; Nikolsky E; Lansky AJ; Aoki J; Moses JW; Steinhubl SR; White HD; Ohman EM; Manoukian SV; Fahy M; Stone GW
    Am Heart J; 2011 Feb; 161(2):298-306.e1. PubMed ID: 21315212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention.
    Rajan L; Moliterno DJ
    Eur Heart J; 2009 Jul; 30(14):1687-9. PubMed ID: 19429914
    [No Abstract]   [Full Text] [Related]  

  • 18. Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update.
    Dobesh PP; Brouse SD; Dager WE; Spinler SA; Stacy Z; Wiggins BS
    Pharmacotherapy; 2007 Dec; 27(12):1722-58. PubMed ID: 18041892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term management and unmet needs after an acute coronary syndrome event.
    Shimada YJ; Scirica BM
    Am J Cardiol; 2015 Mar; 115(5 Suppl):29A-35A. PubMed ID: 25728972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.